OKYO Pharma (OKYO) stock Forecast for 2022 – 2026
Last update: 07-07-2022, 7:56Sector: Healthcare
The share price of OKYO Pharma Limited (OKYO) now
What analysts predict:: $None
52-week high/low: $6.11 / $1.88
50/200 Day Moving Average: $2.249 / $2.249
This figure corresponds to the average price over the previous 50/200 days. For OKYO Pharma stocks, the 50-day moving average is the resistance level today.
For OKYO Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in OKYO Pharma Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the OKYO Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one OKYO Pharma share be worth in 2022 - 2026?
When should I take profit in OKYO Pharma stock? When should I record a loss on OKYO Pharma stock? What are analysts' forecasts for OKYO Pharma stock? What is the future of OKYO Pharma stock?
We forecast OKYO Pharma stock performance using neural networks based on historical data on OKYO Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
OKYO Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for OKYO Pharma shares. This happens once a day.
Historical and forecast chart of OKYO Pharma stock
The chart below shows the historical price of OKYO Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OKYO Pharma stock price can be found in the table below.
Long-term forecasts by years.
OKYO Pharma daily forecast for a month
OKYO Pharma Daily Price Targets
OKYO Pharma Stock Forecast 07-09-2022.
Pessimistic target level: 2.11
Optimistic target level: 2.31
OKYO Pharma Stock Forecast 07-10-2022.
Pessimistic target level: 1.98
Optimistic target level: 2.31
OKYO Pharma Stock Forecast 07-11-2022.
Pessimistic target level: 2.12
Optimistic target level: 2.39
OKYO Pharma Stock Forecast 07-12-2022.
Pessimistic target level: 2.03
Optimistic target level: 2.19
OKYO Pharma Stock Forecast 07-13-2022.
Pessimistic target level: 2.06
Optimistic target level: 2.25
OKYO Pharma Stock Forecast 07-14-2022.
Pessimistic target level: 2.20
Optimistic target level: 2.45
OKYO (OKYO) Monthly Stock Prediction for 2022
OKYO Pharma forecast for this year
OKYO Pharma Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $2.2365. Pessimistic: $2.01. Optimistic: $2.61
OKYO Pharma Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $2.21973. Pessimistic: $2.02. Optimistic: $2.60
OKYO Pharma Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $2.33626. Pessimistic: $2.06. Optimistic: $2.58
OKYO Pharma Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $2.06759. Pessimistic: $1.90. Optimistic: $2.43
OKYO Pharma Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $1.96938. Pessimistic: $1.77. Optimistic: $2.10
OKYO Pharma (OKYO) Monthly Stock Prediction for 2023
OKYO Pharma (OKYO) Monthly Stock Prediction for 2024
OKYO Pharma (OKYO) Monthly Stock Prediction for 2025
OKYO Pharma (OKYO) Monthly Stock Prediction for 2026
OKYO Pharma information and performance
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom.
OKYO Pharma Address
Market Capitalization: 49 007 100 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -4 544 570 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: -10.13
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 21769900
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.